
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 12 chart positions in 12 markets.
By chart position
- 🇦🇺AU · Medicine#1955K to 30K
- 🇳🇱NL · Medicine#6310K to 30K
- 🇰🇷KR · Medicine#9110K to 30K
- 🇯🇵JP · Medicine#1241K to 10K
- 🇲🇽MX · Medicine#1731K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
22K to 86K🎙 Weekly cadence·160 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
43K to 172K🇦🇺17%🇳🇱17%🇰🇷17%+9 more - Active Followers
Loyal subscribers who consistently listen
13K to 52K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Why has the UK government banned social media for under-16s?
Jun 17, 2026
16m 27s
Bioethics flashpoints of the next decade
Jun 2, 2026
36m 14s
The story of Dr Wu Lien-Teh
May 1, 2026
33m 58s
What happened when cannabis was legalised in the US?
Apr 17, 2026
33m 24s
Health in India and global funding cuts
Mar 9, 2026
52m 55s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/17/26 | ![]() Why has the UK government banned social media for under-16s? | The UK Government has just announced a ban on social media for under 16-year-olds. Why? Why now? And will it actually improve young people's health and wellbeing? Lancet Editor Niall Boyce is joined by Esther Lau, Editor-in-Chief of The Lancet Child and Adolescent Health, to discuss the key issues and likely consequences. The Lancet Voice is part of the Lancet Group podcast offering. Editorial team: Niall Boyce, Miriam Sabin, Jessamy Bagenal, Richard Horton, and Gavin Cleaver Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at thelancet.comFollow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv | 16m 27s | ||||||
| 6/2/26 | ![]() Bioethics flashpoints of the next decade✨ | bioethicshealth care+3 | Ezekiel Emanuel | The Lancet GroupThe Lancet Voice | — | bioethicshealth care providers+3 | — | 36m 14s | |
| 5/1/26 | ![]() The story of Dr Wu Lien-Teh✨ | public healthmedical history+3 | Dr Yvonne Ho | — | Manchuria | Dr Wu Lien-Tehpublic health+7 | — | 33m 58s | |
| 4/17/26 | ![]() What happened when cannabis was legalised in the US?✨ | cannabis legalizationhealth effects+3 | Professor Deborah Hasin | Columbia UniversityThe Lancet Group | — | cannabislegalization+5 | — | 33m 24s | |
| 3/9/26 | ![]() Health in India and global funding cuts✨ | global healthfunding cuts+3 | RichardJessamy | The LancetThe Lancet Global Health+2 | — | global healthIndia+3 | — | 52m 55s | |
| 2/24/26 | ![]() Ami Baba and Martin Offringa on SPIRIT-C and CONSORT-C child and adolescent extensions✨ | clinical trialsSPIRIT guidelines+3 | Ami BabaMartin Offringa | The Lancet Child & Adolescent HealthBMJ+1 | — | clinical trialsSPIRIT+5 | — | 25m 05s | |
| 1/15/26 | ![]() The fallout of COP30✨ | sustainable healthcareCOP30+3 | Iris Blom | London School of Hygiene & Tropical MedicineThe Lancet Commission on Sustainable Healthcare | Brazil Amazon | COP30sustainable healthcare+4 | — | 22m 45s | |
| 1/2/26 | ![]() Mumtaz Patel on UK NHS workforce and training issues✨ | NHS workforcetraining issues+3 | Mumtaz Patel | RCP | — | NHSworkforce+5 | — | 42m 50s | |
| 10/30/25 | ![]() Seth Berkley on vaccines, COVID, and equity✨ | vaccinesCOVID-19+4 | Dr. Seth Berkley | Gavi, the Vaccine AllianceCOVAX+1 | — | vaccinesCOVID-19+6 | — | 31m 31s | |
| 10/16/25 | ![]() Alzheimer’s, liver cancer, and research in China✨ | Alzheimer's diseaseliver cancer+4 | RichardJessamy | LancetLancet Group+2 | — | Alzheimer'sliver cancer+5 | — | 39m 38s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/2/25 | ![]() The EAT-Lancet Commission on healthy, sustainable, and just food systems✨ | healthy food systemssustainability+4 | Walter WillettShakuntala Thilsted+1 | EAT-Lancet CommissionLancet+1 | — | EAT-Lancetfood systems+5 | — | 40m 19s | |
| 9/19/25 | ![]() Making scientific research work for women | Scientific research has traditionally treated the male body as the default, resulting in health inequity and poor outcomes for women in a world not designed for them. The Sex and Gender Equity in Research (SAGER) guidelines are an attempt to make sure research is designed for everyone, and that the outcomes better serve everyone. Editor-in-chief of The Lancet Haematology Lan-Lan Smith and editor-in-chief of The Lancet Regional Health Americas Taissa Vila join Gavin to discuss how the history ... | 27m 04s | ||||||
| 8/28/25 | ![]() ”Doctored”, plastics, and NCDs | Gavin, Richard, and Jessamy enter the studio once more for a Lancet Voice chat. A new book on Alzheimer's disease causes controversy across the Lancet team, we discuss the new Countdown on Plastics & Health, and a quick look at the problems facing the upcoming UN High Level Meeting on NCDs. You can read the Lancet Countdown on health and plastics here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01447-3/fulltext?dgcid=buzzsprout_tlv_podcast_August_25_lancet Send us ... | 44m 04s | ||||||
| 8/14/25 | ![]() Step counts and health outcomes - 7,000 or 10,000? | Where did the 10,000 steps recommendation come from? Why has it proven so stubborn? What's the science behind the new recommendations? How strong is the evidence? Professor Melody Ding joins Gavin to talk about her new systematic review published in The Lancet Public Health, examining the relationship between step counts and health outcomes. We also explore the challenges of measuring physical activity, the importance of inclusive research, and the role of environmental and policy interventio... | 27m 24s | ||||||
| 7/31/25 | ![]() The next generation of weight-loss drugs | It’s no exaggeration to say that the past decade has revolutionized how we think about and treat obesity. Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have dominated headlines, enabling significant weight loss at speeds once considered unthinkable. The market for innovative weight loss medications is booming, with pharmaceutical companies investing heavily in hopes of developing the next blockbuster drug. However, amid this race for market dominance, many experts are questioning... | 38m 11s | ||||||
| 7/17/25 | ![]() One Health | The sustainability of our existence relies on the health of every human, every animal, and the environment we all share. Published today, "The Lancet One Health Commission: harnessing our interconnectedness for equitable, sustainable, and healthy socioecological systems" highlights challenges like climate change, food security, and antimicrobial resistance to lay out the One Health approach to informing and implementing solutions. Senior Executive Editor at The Lancet Pam Das is joined by lea... | 43m 08s | ||||||
| 7/3/25 | ![]() Proof, truth, and infectious disease | Professor Adam Kucharski joins Gavin & Jessamy to discuss the intersection of mathematics, epidemiology, and truth, off the back of his new book, Proof. How do we generate scientific knowledge? How can we communicate uncertainty? What is the impact of social media and artificial intelligence on public trust in science? Adam also tells us about the importance of public engagement, the nuances of misinformation, the importance of transparency in policy, the future of scientific communicatio... | 38m 23s | ||||||
| 6/19/25 | ![]() Femtech and women’s health | How safe is it to use period tracking and digital contraception apps? Who is your data being shared with? What regulation actually exists in this area to protect app users? Femtech offers women digital tools for tracking reproductive health. Gavin and Jessamy are joined by Dr. Catriona McMillan, Senior Research Fellow in Medical Law and Ethics at the University of Edinburgh, to talk about how accurate these apps actually are, significant concerns about data privacy, and what regulatory oversi... | 25m 00s | ||||||
| 6/5/25 | ![]() The World Health Assembly, adolescent health, and the pace of innovation | Richard, Jessamy, and Gavin reflect on developments at the 78th World Health Assembly, including the passage of the pandemic agreement and shifting dynamics in global health leadership. What's next for WHO without US engagement? How has WHA changed over the years? We also address the importance of recommitting to adolescent health following our new Commission, and discuss a controversial recent study about the pace of scientific innovation. You can read the second Lancet Commission on Adolesc... | 44m 20s | ||||||
| 5/22/25 | ![]() Human flourishing and research funding | Gavin, Richard, and Jessamy return to the studio to discuss some publications that caught their eye this month, and in doing so set themselves the lofty goal of examining how meaning, purpose, optimism, and social context shape our understanding of health beyond traditional clinical measures. We also ponder the future of research and higher education in the face of funding challenges in both the US and the UK. Articles mentioned in this episode: The Global Flourishing Study: https://www.natur... | 38m 19s | ||||||
| 5/8/25 | ![]() Labour’s record on UK health | Gavin and Jessamy welcome Dr. Hugh Alderwick from the Health Foundation to The Lancet Voice as we explore the impact of the Labour government's health policies since coming to power in the UK. What might the anticipated 10-year plan for the NHS look like? What are the implications of dismantling NHS England? Will any government get a handle on social care? Hugh also provides expert analysis on the balance between funding and reform, the role of AI in health care, and the pressing issue of im... | 34m 33s | ||||||
| 4/24/25 | ![]() How US actions are affecting health security across Ukraine & Europe | Gavin and Jessamy welcome back Oksana Pyzik of UCL to talk about the significant impacts of Trump's actions on health infrastructure in Ukraine and broader Europe. Oksana provides a comprehensive update on the current health situation in Ukraine, the challenges faced by healthcare systems amidst ongoing conflict, and the repercussions of halted aid on crucial programs like HIV and TB. We also explore the response of international institutions responsible for coordinated efforts to addre... | 43m 24s | ||||||
| 4/10/25 | ![]() US health under Trump, gender justice, and child mortality | Gavin, Richard, and Jessamy reunite for another bonus episode, covering the first three months or so of health in the US under Trump. What do the appointments tell us about the administration's agenda? How can institutions stand up to cuts and intimidation? We also look at gender justice in global health as laid out by the excellent new Commission in The Lancet, and highlight that the world's impressive gains on maternal and newborn mortality are slowing - what more needs to be done? Yo... | 47m 43s | ||||||
| 3/27/25 | ![]() Bird flu on the rise | Following the discovery of H5N1 influenza of avian origin in a sheep in the UK this week, Gavin is joined by Dr. Abraar Karan of Stanford University to discuss the current state of bird flu in the US, its impact on public health, and the potential for human-to-human transmission. Dr. Karan analyses the ongoing outbreaks and infections in the US, the challenges in detecting and controlling the virus, and the lessons learned from COVID-19. We chat about the complexities of viral evolution, the ... | 40m 37s | ||||||
| 3/17/25 | ![]() Sexual assault, stigma, health, and society | Content warning: discussions of sexual assault, violence, and rape How does society handle sexual assault? What are the health implications for victims and for populations? Did the Pelicot case change attitudes and what can we do to address stigma? Gavin is joined by Professor Betsy Stanko OBE and Professor Katrin Hohl OBE, who together worked on the London Metropolitan Police's Operation Soteria to change how the police deal with sexual assault cases. In this episode, we explor... | 44m 50s | ||||||
Showing 25 of 164
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
12 placements across 12 markets.
Chart Positions
12 placements across 12 markets.

